2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Weighted Average Number Of Diluted Shares Outstanding | NA | 37.45 | NA | NA | NA | 37.21 | NA | NA | NA | NA | |
Weighted Average Number Of Shares Outstanding Basic | NA | 37.45 | 37.52 | 37.43 | NA | 37.21 | NA | 1.98 | 1.94 | 1.93 | |
Weighted Average Number Of Share Outstanding Basic And Diluted | NA | NA | 37.29 | 37.13 | NA | 37.21 | NA | 2.11 | 2.09 | 2.08 | |
Earnings Per Share Basic | -0.53 | -0.58 | NA | NA | -0.73 | -0.63 | NA | NA | NA | NA | |
Earnings Per Share Diluted | -0.53 | -0.58 | NA | NA | -0.73 | -0.63 | NA | NA | NA | NA | |
Earnings Per Share Basic And Diluted | NA | NA | -0.61 | -0.64 | -0.73 | -0.63 | -14.70 | -4.73 | -5.29 | -4.16 |
2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.41 | 2.11 | 1.39 | 0.81 | 0.51 | 0.75 | 0.00 | 0.00 | 0.07 | 0.16 | |
Operating Expenses | 22.45 | 24.46 | 24.45 | 24.69 | 27.58 | 24.28 | 16.92 | 12.40 | 11.18 | 8.91 | |
Research And Development Expense | 16.84 | 18.97 | 18.92 | 18.39 | 22.48 | 19.34 | 14.86 | 9.54 | 9.17 | 6.79 | |
General And Administrative Expense | 5.61 | 5.49 | 5.53 | 6.30 | 5.10 | 4.94 | 2.06 | 2.87 | 2.01 | 2.12 | |
Operating Income Loss | -21.04 | -22.35 | -23.06 | -23.88 | -27.07 | -23.53 | -16.92 | -12.40 | -11.11 | -8.74 | |
Allocated Share Based Compensation Expense | 2.12 | 2.14 | 2.39 | 2.92 | 2.14 | 2.23 | 0.57 | 0.40 | 0.22 | 0.23 | |
Profit Loss | -20.00 | -21.76 | -22.66 | -23.68 | -27.16 | -23.39 | -31.04 | -10.00 | -11.06 | -8.63 | |
Net Income Loss | -20.00 | -21.76 | -22.66 | -23.68 | -27.16 | -23.39 | -31.04 | -10.00 | -11.06 | -8.63 | |
Comprehensive Income Net Of Tax | -19.21 | -21.66 | -23.07 | -24.75 | -27.44 | -23.41 | -31.04 | -10.00 | -11.05 | -8.64 |
2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets | 227.81 | 245.50 | 260.24 | 282.79 | 307.72 | 333.55 | 46.54 | NA | NA | NA | |
Liabilities | 56.30 | 57.06 | 52.27 | 54.40 | 57.60 | 58.64 | 46.19 | NA | NA | NA | |
Liabilities And Stockholders Equity | 227.81 | 245.50 | 260.24 | 282.79 | 307.72 | 333.55 | 46.54 | NA | NA | NA | |
Stockholders Equity | 171.51 | 188.45 | 207.97 | 228.39 | 250.12 | 274.91 | -104.95 | -74.59 | -65.04 | -54.23 |
2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Assets Current | 172.75 | 174.83 | 181.26 | 196.09 | 189.16 | 222.49 | 25.36 | NA | NA | NA | |
Cash And Cash Equivalents At Carrying Value | 9.24 | 10.62 | 22.62 | 44.02 | 27.38 | 23.65 | 5.54 | 17.79 | 45.31 | 11.61 | |
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents | 10.81 | 12.18 | 24.18 | 45.59 | 28.95 | 25.21 | 7.11 | 19.36 | 45.89 | 12.20 | |
Short Term Investments | 159.64 | 160.51 | 153.72 | 146.88 | 158.84 | 189.24 | 17.30 | NA | NA | NA | |
Prepaid Expense And Other Assets Current | 3.86 | 3.70 | 4.93 | 5.19 | 2.94 | 9.60 | 2.52 | NA | NA | NA | |
Available For Sale Securities Debt Securities | 183.59 | 198.94 | 201.00 | 201.19 | 244.18 | 266.88 | 17.30 | NA | NA | NA |
2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Property Plant And Equipment Gross | 10.37 | 10.36 | 9.54 | 9.24 | 8.40 | 7.69 | 5.32 | NA | NA | NA | |
Accumulated Depreciation Depletion And Amortization Property Plant And Equipment | 3.92 | 3.45 | 3.01 | 2.61 | 2.25 | 2.06 | 1.24 | NA | NA | NA | |
Property Plant And Equipment Net | 6.45 | 6.91 | 6.53 | 6.64 | 6.16 | 5.63 | 4.08 | NA | NA | NA | |
Long Term Investments | 23.94 | 38.43 | 47.28 | 54.31 | 85.35 | 77.64 | NA | NA | NA | NA | |
Other Assets Noncurrent | 1.03 | 1.00 | 1.00 | 0.92 | 1.04 | 0.99 | 0.88 | NA | NA | NA | |
Available For Sale Debt Securities Amortized Cost Basis | 184.51 | 200.65 | 202.80 | 202.58 | 244.50 | 266.92 | 17.30 | NA | NA | NA |
2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Liabilities Current | 23.12 | 24.17 | 18.62 | 19.31 | 21.33 | 23.70 | 11.26 | NA | NA | NA | |
Accounts Payable Current | 3.59 | 3.83 | 3.36 | 4.45 | 3.57 | 5.16 | 1.60 | NA | NA | NA | |
Other Accrued Liabilities Current | 0.96 | 1.37 | 0.91 | 1.96 | 1.20 | 0.84 | 0.58 | NA | NA | NA | |
Contract With Customer Liability Current | 1.40 | NA | NA | NA | NA | NA | NA | NA | NA | NA |
2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Other Liabilities Noncurrent | 0.04 | 0.20 | 0.20 | 0.20 | 0.21 | 0.22 | 0.33 | NA | NA | NA | |
Operating Lease Liability Noncurrent | 20.22 | 20.86 | 20.75 | 21.31 | 21.85 | 22.52 | 9.38 | NA | NA | NA |
2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Stockholders Equity | 171.51 | 188.45 | 207.97 | 228.39 | 250.12 | 274.91 | -104.95 | -74.59 | -65.04 | -54.23 | |
Additional Paid In Capital Common Stock | 467.51 | 465.25 | 463.10 | 460.46 | 457.43 | 454.78 | 3.45 | NA | NA | NA | |
Retained Earnings Accumulated Deficit | -295.09 | -275.09 | -253.33 | -230.67 | -206.99 | -179.83 | -108.40 | NA | NA | NA | |
Accumulated Other Comprehensive Income Loss Net Of Tax | -0.92 | -1.71 | -1.80 | -1.40 | -0.32 | -0.04 | NA | NA | NA | NA | |
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value | 2.12 | 2.14 | 2.39 | 2.92 | 2.14 | 2.23 | 0.57 | 0.40 | 0.22 | 0.23 |
2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | -17.95 | -13.45 | -20.79 | -24.31 | -17.79 | -18.73 | -12.89 | -12.52 | -12.27 | -9.64 | |
Net Cash Provided By Used In Investing Activities | 16.43 | 1.45 | -0.87 | 40.84 | 21.03 | -16.11 | 1.70 | -13.10 | 4.41 | -13.61 | |
Net Cash Provided By Used In Financing Activities | 0.14 | 0.00 | 0.25 | 0.11 | 0.49 | 0.18 | -1.06 | -0.92 | 41.55 | 0.03 |
2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Operating Activities | -17.95 | -13.45 | -20.79 | -24.31 | -17.79 | -18.73 | -12.89 | -12.52 | -12.27 | -9.64 | |
Net Income Loss | -20.00 | -21.76 | -22.66 | -23.68 | -27.16 | -23.39 | -31.04 | -10.00 | -11.06 | -8.63 | |
Profit Loss | -20.00 | -21.76 | -22.66 | -23.68 | -27.16 | -23.39 | -31.04 | -10.00 | -11.06 | -8.63 | |
Depreciation Depletion And Amortization | 0.46 | 0.44 | 0.41 | 0.36 | 0.36 | 0.30 | 0.22 | 0.18 | 0.11 | 0.10 | |
Share Based Compensation | 2.12 | 2.14 | 2.39 | 2.92 | 2.14 | 2.23 | 0.57 | 0.40 | 0.22 | 0.23 |
2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Investing Activities | 16.43 | 1.45 | -0.87 | 40.84 | 21.03 | -16.11 | 1.70 | -13.10 | 4.41 | -13.61 | |
Payments To Acquire Property Plant And Equipment | 0.18 | 0.73 | 0.43 | 0.60 | 0.56 | 1.01 | 0.90 | 1.15 | 0.84 | 0.37 |
2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Net Cash Provided By Used In Financing Activities | 0.14 | 0.00 | 0.25 | 0.11 | 0.49 | 0.18 | -1.06 | -0.92 | 41.55 | 0.03 |
2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | ||
---|---|---|---|---|---|---|---|---|---|---|---|
Revenues | 1.41 | 2.11 | 1.39 | 0.81 | 0.51 | 0.75 | 0.00 | 0.00 | 0.07 | 0.16 | |
Genmab Agreement | 1.20 | 1.40 | 1.00 | 0.60 | 0.50 | 0.80 | NA | NA | NA | NA | |
Innovent Agreement | 0.20 | 0.70 | 0.40 | 0.20 | NA | NA | NA | NA | NA | NA |